CompumedicsASX:CMP -4.00%61 1-Year ROIIC % is 51.54 as of Dec. 2025. GuruFocus rates ASX:CMP with a GF Score™ of 61/100 and a GF Value™ of A$0.31 (Modestly Undervalued). The stock has 6 warning signs investors should review. Among 824 Medical Devices & Instruments companies, Compumedics ranks better than 79.49% on this metric.
1-Year Return on Invested Incremental Capital (1-Year ROIIC %) measures the change in earnings as a percentage of change in investment over 1-year.
Compumedics's 1-Year ROIIC % for the quarter that ended in Dec. 2025 was 51.54%. High ROIIC is generally an indication that your business is capital efficient or has a higher operating leverage.
The industry rank for Compumedics's 1-Year ROIIC % or its related term are showing as below:
ASX:CMP's 1-Year ROIIC % is ranked better than 79.49% of 824
companies
in the Medical Devices & Instruments industry
Industry Median: 0.44
vs ASX:CMP: 51.54
Compumedics (ASX:CMP) 1-Year ROIIC % Explanation
Return on Incremental Invested Capital (ROIIC) is an extension of Return on Investment Capital (ROIC). ROIC % tells investors how efficiently that profitability is earned per dollar of company capital. ROIIC narrows the focus even further and shows how profitable each additional unit of capital investment could be. ROIIC % is a more powerful metric than ROIC because it measures how much money the company can generate going forward on future capital investments.
High ROIIC is generally an indication that your business is capital efficient or has a higher operating leverage.
Be Aware
It's important to keep in mind that when tracking ROIIC, the metric is better suited to forecasting the trend of future returns rather than measuring current return on investment.
Compumedics 1-Year ROIIC % Related Terms
Compumedics 1-Year ROIIC % Historical Data
* Premium members only.
The historical data trend for Compumedics's 1-Year ROIIC % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
ASX:CMP vs ABT, SYK, MDT: 1-Year ROIIC % Comparison
For the Medical Devices subindustry, Compumedics's 1-Year ROIIC %, along with its competitors' market caps and 1-Year ROIIC % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Compumedics 1-Year ROIIC % vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Compumedics's 1-Year ROIIC % distribution charts can be found below:
* The bar in red indicates where Compumedics's 1-Year ROIIC % falls into.
Compumedics's 1-Year ROIIC % for the quarter that ended in Dec. 2025 is calculated as:
1-Year ROIIC %
=
1-Year Incremental Net Operating Profit After Taxes (NOPAT)**
/
1-Year Incremental Invested Capital
=
( 0.0096 (Dec. 2025) - -3.015 (Dec. 2024) )
/
( 42.394 (Dec. 2025) - 36.525 (Dec. 2024) )
=
3.0246
/
5.869
=
51.54%***
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
** TTM data of NOPAT and Invested Capital was used to calculate 1-Year ROIIC %.
*** Please be aware that the ROIIC (Return on Invested Capital) calculations are based on company-level data using the primary share class. The calculated data provided is for demonstration purposes and may slightly differ from the results displayed in the title due to potential variations caused by currency exchange rate differences throughout the year.
Compumedics (ASX:CMP) has a 1-Year ROIIC % of 51.54 as of Dec. 2025. 1-Year ROIIC % measures the change in earnings as a percentage of change in investment over 1-year. View historical data on Compumedics and its competitors. According to the industry distribution chart, Compumedics ranks #169 out of 824 companies in the Medical Devices & Instruments industry, placing it in the top 20.5%.
Is Compumedics' 1-Year ROIIC % too high?
Compumedics' current 1-Year ROIIC % is 51.54. The Medical Devices & Instruments industry median 1-Year ROIIC % is 0.44. Compumedics' value of 51.54 is 11613.6% above this industry median. Based on the distribution chart, Compumedics ranks #169 out of 824 companies in the Medical Devices & Instruments industry, which is in the top quartile — a strong position relative to peers. Overall, Compumedics has a GF Score™ of 61/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Compumedics' 1-Year ROIIC % compare to ABT and SYK?
According to the Medical Devices & Instruments industry distribution chart, Compumedics ranks #169 out of 824 companies for 1-Year ROIIC %. This places Compumedics in the top 21% of its industry — outperforming the majority of peers. The industry median 1-Year ROIIC % is 0.44. Compumedics' value of 51.54 is 11613.6% above this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 1-Year ROIIC % for a Medical Devices & Instruments company?
The median 1-Year ROIIC % among Medical Devices & Instruments companies is 0.44, based on 824 companies in the industry. Companies in the top quartile (top 25%) have a 1-Year ROIIC % significantly above this median, while those in the bottom quartile fall well below. However, 1-Year ROIIC % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Compumedics's current 1-Year ROIIC % of 51.54 is 11613.6% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 1-Year ROIIC % mean?
A high 1-Year ROIIC % can signal that a stock is expensive relative to its fundamentals. 1-Year ROIIC % measures the change in earnings as a percentage of change in investment over 1-year. View historical data on Compumedics and its competitors. For the Medical Devices & Instruments industry, the median 1-Year ROIIC % is 0.44 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Compumedics's current 1-Year ROIIC % is 51.54. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Compumedics stock overvalued right now?
Based on GuruFocus' analysis, Compumedics (ASX:CMP) is currently considered Modestly Undervalued. The stock's GF Value™ is A$0.31, compared to a current price of A$0.24 — trading 22.6% below its estimated fair value. The current 1-Year ROIIC % is 51.54 and 11613.6% above the Medical Devices & Instruments industry median of 0.44. Compumedics' overall GF Score™ is 61/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 1-Year ROIIC % calculated?
1-Year ROIIC % is calculated from a company's financial statements. For Compumedics (ASX:CMP), the current 1-Year ROIIC % is 51.54 as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Compumedics (ASX:CMP) Overvalued in 2026?
Based on GuruFocus' analysis, Compumedics stock appears to be undervalued.
The current stock price of A$0.24 is trading 22.6% below its estimated GF Value™ of A$0.31.
GuruFocus considers Compumedics to be Modestly Undervalued.
Key valuation signals for ASX:CMP:
1-Year ROIIC %: 51.54
GF Value™: A$0.31 vs. price of A$0.24 (22.6% below fair value)
Industry Position: 11613.6% above the Medical Devices & Instruments median (#169 of 824)
No single metric tells the full story. See the ASX:CMP stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Compumedics Ltd is a medical device company. It is engaged in the development, manufacturing, and commercialization of diagnostic technologies for sleep, brain, and ultrasonic blood-flow monitoring applications. The company is organized into geographical operating segments, being the United States of America, Australia and Asia Pacific, and Europe and the Middle East. It derives a majority of its revenue from Australia and the Asia Pacific region.
61GF Score
Get the complete analysis for ASX:CMP
1-Year ROIIC % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
ASX:CMP has been successfully added to your 
